JPRN-jRCT1030220064进行中（未招募）未知
An observational study to investigate outcomes and post-treatment status after completion of study treatment in patients who participated in the investigator-initiated Trastuzumab combIned with pertuzumab for patients with HER2 positive mCRC (TRIUMPH Study)
akamura Yoshiaki0 个研究点目标入组 30 人开始时间: 2022年5月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •All patients who participated in the TRIUMPH study
排除标准
- •Patients withdrawing consent for the TRIUMPH trial as of the end of April 2022
研究者
相似试验
已完成
不适用
Study of Arrest Outcome Consortium Registry AnalysisCTRI/2019/09/021048Dr Anuj Clerk127
尚未招募
不适用
A study to observe and compare the Postoperative Bleeding, ABG Values, Arrhythmias, Extubation Time, Prolonged Stay In Critical Care Unit, Mortality , prolonged Ionotropic Requirement, Postoperative infection among on pump and off pump postoperative CABG patients.CTRI/2021/08/035433anu Jenychim Aimol
招募中
不适用
Observational study investigating the efficacy and safety of fulvestrant + CDK4 / 6 inhibitor as a primary endocrine therapy for hormone receptor-positive, HER2-negative advanced/metastatic breast cancerBreast cancerJPRN-UMIN000043917Breast Surgery, Yokkaichi Municipal Hospital30
尚未招募
不适用
Study On Quality Outcomes In Burn PatientsCTRI/2018/01/011564Department of Hospital Administration
进行中（未招募）
不适用
An observational study to investigate the incidence of influenza and influenza-related complications, in adults between 50-64 years and elderly adults 65 years and over vaccinated with GSK Biologicals’ influenza vaccine (Fluarix™) administered intramuscularly - EPI-FLUAS25-002Immunization against influenza in male and female subjects aged 50 years and overEUCTR2006-002897-23-DEGlaxoSmithKline Biologicals3,000